This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Immunome, Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Michael John Morin: Innovator in Antibody Development
Introduction
Michael John Morin is a notable inventor based in Salisbury, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of treatments for viral infections. His innovative work has led to the creation of a patent that addresses a pressing global health issue.
Latest Patents
Michael John Morin holds a patent for an "Antibody cocktail against SARS-CoV-2 spike protein." This patent includes antibodies that are useful for treating SARS-CoV-2 infections in a subject. The patent also encompasses compositions comprising one or more antibodies, methods of treatment involving the administration of these antibodies, and kits that include one or more antibodies. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Morin is currently associated with Immunome, Inc., a company dedicated to developing innovative therapies. His work at Immunome focuses on harnessing the power of antibodies to combat infectious diseases. His contributions are vital in the ongoing fight against COVID-19 and other viral threats.
Collaborations
Throughout his career, Michael has collaborated with talented individuals such as Matthew K. Robinson and Pavel Nikitin. These partnerships have enhanced the research and development efforts at Immunome, leading to promising advancements in antibody therapies.
Conclusion
Michael John Morin is a pioneering inventor whose work in antibody development is making a significant impact in the field of medicine. His innovative patent for an antibody cocktail against SARS-CoV-2 highlights his dedication to addressing global health challenges.